Global Gastrointestinal Disorder Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 1013237 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Irritable Bowel Syndrome (IBS)
        1.2.3 Chronic Constipation (CC)
        1.2.4 Ulcerative Colitis (UC)
    1.3 Market by Application
        1.3.1 Global Gastrointestinal Disorder Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Gastrointestinal Disorder Therapeutics Market Perspective (2016-2027)
    2.2 Gastrointestinal Disorder Therapeutics Growth Trends by Regions
        2.2.1 Gastrointestinal Disorder Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Gastrointestinal Disorder Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Gastrointestinal Disorder Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Gastrointestinal Disorder Therapeutics Industry Dynamic
        2.3.1 Gastrointestinal Disorder Therapeutics Market Trends
        2.3.2 Gastrointestinal Disorder Therapeutics Market Drivers
        2.3.3 Gastrointestinal Disorder Therapeutics Market Challenges
        2.3.4 Gastrointestinal Disorder Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Gastrointestinal Disorder Therapeutics Players by Revenue
        3.1.1 Global Top Gastrointestinal Disorder Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Gastrointestinal Disorder Therapeutics Revenue
    3.4 Global Gastrointestinal Disorder Therapeutics Market Concentration Ratio
        3.4.1 Global Gastrointestinal Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Disorder Therapeutics Revenue in 2020
    3.5 Gastrointestinal Disorder Therapeutics Key Players Head office and Area Served
    3.6 Key Players Gastrointestinal Disorder Therapeutics Product Solution and Service
    3.7 Date of Enter into Gastrointestinal Disorder Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Disorder Therapeutics Breakdown Data by Type
    4.1 Global Gastrointestinal Disorder Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Type (2022-2027)

5 Gastrointestinal Disorder Therapeutics Breakdown Data by Application
    5.1 Global Gastrointestinal Disorder Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Gastrointestinal Disorder Therapeutics Market Size (2016-2027)
    6.2 North America Gastrointestinal Disorder Therapeutics Market Size by Type
        6.2.1 North America Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Gastrointestinal Disorder Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2027)
    6.3 North America Gastrointestinal Disorder Therapeutics Market Size by Application
        6.3.1 North America Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Gastrointestinal Disorder Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2027)
    6.4 North America Gastrointestinal Disorder Therapeutics Market Size by Country
        6.4.1 North America Gastrointestinal Disorder Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Gastrointestinal Disorder Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Gastrointestinal Disorder Therapeutics Market Size (2016-2027)
    7.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Type
        7.2.1 Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Application
        7.3.1 Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Gastrointestinal Disorder Therapeutics Market Size by Country
        7.4.1 Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Gastrointestinal Disorder Therapeutics Market Size (2016-2027)
    9.2 Latin America Gastrointestinal Disorder Therapeutics Market Size by Type
        9.2.1 Latin America Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Gastrointestinal Disorder Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Gastrointestinal Disorder Therapeutics Market Size by Application
        9.3.1 Latin America Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Gastrointestinal Disorder Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Gastrointestinal Disorder Therapeutics Market Size by Country
        9.4.1 Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Introduction
        11.1.4 AstraZeneca Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.1.5 AstraZeneca Recent Development
    11.2 Takeda Pharmaceutical
        11.2.1 Takeda Pharmaceutical Company Details
        11.2.2 Takeda Pharmaceutical Business Overview
        11.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Introduction
        11.2.4 Takeda Pharmaceutical Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.2.5 Takeda Pharmaceutical Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Gastrointestinal Disorder Therapeutics Introduction
        11.3.4 Johnson & Johnson Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.3.5 Johnson & Johnson Recent Development
    11.4 Eisai
        11.4.1 Eisai Company Details
        11.4.2 Eisai Business Overview
        11.4.3 Eisai Gastrointestinal Disorder Therapeutics Introduction
        11.4.4 Eisai Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.4.5 Eisai Recent Development
    11.5 Abbott Laboratories
        11.5.1 Abbott Laboratories Company Details
        11.5.2 Abbott Laboratories Business Overview
        11.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Introduction
        11.5.4 Abbott Laboratories Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.5.5 Abbott Laboratories Recent Development
    11.6 Salix Pharmaceuticals
        11.6.1 Salix Pharmaceuticals Company Details
        11.6.2 Salix Pharmaceuticals Business Overview
        11.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Introduction
        11.6.4 Salix Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.6.5 Salix Pharmaceuticals Recent Development
    11.7 Bausch Health
        11.7.1 Bausch Health Company Details
        11.7.2 Bausch Health Business Overview
        11.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Introduction
        11.7.4 Bausch Health Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.7.5 Bausch Health Recent Development
    11.8 Allergan
        11.8.1 Allergan Company Details
        11.8.2 Allergan Business Overview
        11.8.3 Allergan Gastrointestinal Disorder Therapeutics Introduction
        11.8.4 Allergan Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.8.5 Allergan Recent Development
    11.9 Bayer
        11.9.1 Bayer Company Details
        11.9.2 Bayer Business Overview
        11.9.3 Bayer Gastrointestinal Disorder Therapeutics Introduction
        11.9.4 Bayer Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.9.5 Bayer Recent Development
    11.10 UCB
        11.10.1 UCB Company Details
        11.10.2 UCB Business Overview
        11.10.3 UCB Gastrointestinal Disorder Therapeutics Introduction
        11.10.4 UCB Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.10.5 UCB Recent Development
    11.11 AbbVie
        11.11.1 AbbVie Company Details
        11.11.2 AbbVie Business Overview
        11.11.3 AbbVie Gastrointestinal Disorder Therapeutics Introduction
        11.11.4 AbbVie Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.11.5 AbbVie Recent Development
    11.12 GlaxoSmithKline
        11.12.1 GlaxoSmithKline Company Details
        11.12.2 GlaxoSmithKline Business Overview
        11.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Introduction
        11.12.4 GlaxoSmithKline Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.12.5 GlaxoSmithKline Recent Development
    11.13 Astellas Pharma
        11.13.1 Astellas Pharma Company Details
        11.13.2 Astellas Pharma Business Overview
        11.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Introduction
        11.13.4 Astellas Pharma Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021)
        11.13.5 Astellas Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Irritable Bowel Syndrome (IBS)
    Table 3. Key Players of Chronic Constipation (CC)
    Table 4. Key Players of Ulcerative Colitis (UC)
    Table 5. Global Gastrointestinal Disorder Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Gastrointestinal Disorder Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Gastrointestinal Disorder Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Gastrointestinal Disorder Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Gastrointestinal Disorder Therapeutics Market Share by Regions (2022-2027)
    Table 11. Gastrointestinal Disorder Therapeutics Market Trends
    Table 12. Gastrointestinal Disorder Therapeutics Market Drivers
    Table 13. Gastrointestinal Disorder Therapeutics Market Challenges
    Table 14. Gastrointestinal Disorder Therapeutics Market Restraints
    Table 15. Global Gastrointestinal Disorder Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Gastrointestinal Disorder Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top Gastrointestinal Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2020)
    Table 18. Ranking of Global Top Gastrointestinal Disorder Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Gastrointestinal Disorder Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Gastrointestinal Disorder Therapeutics Product Solution and Service
    Table 22. Date of Enter into Gastrointestinal Disorder Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Gastrointestinal Disorder Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Gastrointestinal Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Gastrointestinal Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Gastrointestinal Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Gastrointestinal Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Gastrointestinal Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Gastrointestinal Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. AstraZeneca Company Details
    Table 63. AstraZeneca Business Overview
    Table 64. AstraZeneca Gastrointestinal Disorder Therapeutics Product
    Table 65. AstraZeneca Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. AstraZeneca Recent Development
    Table 67. Takeda Pharmaceutical Company Details
    Table 68. Takeda Pharmaceutical Business Overview
    Table 69. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product
    Table 70. Takeda Pharmaceutical Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. Takeda Pharmaceutical Recent Development
    Table 72. Johnson & Johnson Company Details
    Table 73. Johnson & Johnson Business Overview
    Table 74. Johnson & Johnson Gastrointestinal Disorder Therapeutics Product
    Table 75. Johnson & Johnson Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. Johnson & Johnson Recent Development
    Table 77. Eisai Company Details
    Table 78. Eisai Business Overview
    Table 79. Eisai Gastrointestinal Disorder Therapeutics Product
    Table 80. Eisai Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. Eisai Recent Development
    Table 82. Abbott Laboratories Company Details
    Table 83. Abbott Laboratories Business Overview
    Table 84. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product
    Table 85. Abbott Laboratories Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Abbott Laboratories Recent Development
    Table 87. Salix Pharmaceuticals Company Details
    Table 88. Salix Pharmaceuticals Business Overview
    Table 89. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product
    Table 90. Salix Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. Salix Pharmaceuticals Recent Development
    Table 92. Bausch Health Company Details
    Table 93. Bausch Health Business Overview
    Table 94. Bausch Health Gastrointestinal Disorder Therapeutics Product
    Table 95. Bausch Health Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. Bausch Health Recent Development
    Table 97. Allergan Company Details
    Table 98. Allergan Business Overview
    Table 99. Allergan Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Allergan Recent Development
    Table 101. Bayer Company Details
    Table 102. Bayer Business Overview
    Table 103. Bayer Gastrointestinal Disorder Therapeutics Product
    Table 104. Bayer Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Bayer Recent Development
    Table 106. UCB Company Details
    Table 107. UCB Business Overview
    Table 108. UCB Gastrointestinal Disorder Therapeutics Product
    Table 109. UCB Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 110. UCB Recent Development
    Table 111. AbbVie Company Details
    Table 112. AbbVie Business Overview
    Table 113. AbbVie Gastrointestinal Disorder Therapeutics Product
    Table 114. AbbVie Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 115. AbbVie Recent Development
    Table 116. GlaxoSmithKline Company Details
    Table 117. GlaxoSmithKline Business Overview
    Table 118. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product
    Table 119. GlaxoSmithKline Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 120. GlaxoSmithKline Recent Development
    Table 121. Astellas Pharma Company Details
    Table 122. Astellas Pharma Business Overview
    Table 123. Astellas Pharma Gastrointestinal Disorder Therapeutics Product
    Table 124. Astellas Pharma Revenue in Gastrointestinal Disorder Therapeutics Business (2016-2021) & (US$ Million)
    Table 125. Astellas Pharma Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastrointestinal Disorder Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Irritable Bowel Syndrome (IBS) Features
    Figure 3. Chronic Constipation (CC) Features
    Figure 4. Ulcerative Colitis (UC) Features
    Figure 5. Global Gastrointestinal Disorder Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Gastrointestinal Disorder Therapeutics Report Years Considered
    Figure 10. Global Gastrointestinal Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Gastrointestinal Disorder Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Gastrointestinal Disorder Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 13. Global Gastrointestinal Disorder Therapeutics Market Share by Regions (2022-2027)
    Figure 14. Global Gastrointestinal Disorder Therapeutics Market Share by Players in 2020
    Figure 15. Global Top Gastrointestinal Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Gastrointestinal Disorder Therapeutics Revenue in 2020
    Figure 17. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 18. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 19. North America Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Gastrointestinal Disorder Therapeutics Market Share by Type (2016-2027)
    Figure 21. North America Gastrointestinal Disorder Therapeutics Market Share by Application (2016-2027)
    Figure 22. North America Gastrointestinal Disorder Therapeutics Market Share by Country (2016-2027)
    Figure 23. United States Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Gastrointestinal Disorder Therapeutics Market Share by Type (2016-2027)
    Figure 27. Europe Gastrointestinal Disorder Therapeutics Market Share by Application (2016-2027)
    Figure 28. Europe Gastrointestinal Disorder Therapeutics Market Share by Country (2016-2027)
    Figure 29. Germany Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Share by Region (2016-2027)
    Figure 39. China Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Gastrointestinal Disorder Therapeutics Market Share by Type (2016-2027)
    Figure 47. Latin America Gastrointestinal Disorder Therapeutics Market Share by Application (2016-2027)
    Figure 48. Latin America Gastrointestinal Disorder Therapeutics Market Share by Country (2016-2027)
    Figure 49. Mexico Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Share by Country (2016-2027)
    Figure 55. Turkey Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. AstraZeneca Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 59. Takeda Pharmaceutical Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 60. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 61. Eisai Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 62. Abbott Laboratories Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 63. Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 64. Bausch Health Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 65. Allergan Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 66. Bayer Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 67. UCB Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 68. AbbVie Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 69. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 70. Astellas Pharma Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Takeda Pharmaceutical
Johnson & Johnson
Eisai
Abbott Laboratories
Salix Pharmaceuticals
Bausch Health
Allergan
Bayer
UCB
AbbVie
GlaxoSmithKline
Astellas Pharma
Frequently Asked Questions
Gastrointestinal Disorder Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Disorder Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Disorder Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gene Editing

Gemstones are elements of minerals which when polished and cut are used for making jewelry and ot ... Read More

Genomic Medicine

Market Analysis and Insights: Global Genomic Medicine Market
The global Genomic Med ... Read More